 | • レポートコード：B-GIR09D4079 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、レビー小体型認知症治療の世界市場について調べ、まとめました。種類別セグメントは、モダフィニル、ベンゾジアゼピン、抗うつ剤、コリンエステラーゼ阻害剤、抗精神病薬、カルビドパ-レボドパ等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。レビー小体型認知症治療の世界市場概観、企業動向、企業別レビー小体型認知症治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・レビー小体型認知症治療の市場概観 ・レビー小体型認知症治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・レビー小体型認知症治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・レビー小体型認知症治療の世界市場規模 ・レビー小体型認知症治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・レビー小体型認知症治療のアメリカ市場規模推移 ・レビー小体型認知症治療のカナダ市場規模推移 ・レビー小体型認知症治療のメキシコ市場規模推移 ・レビー小体型認知症治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・レビー小体型認知症治療のドイツ市場規模推移 ・レビー小体型認知症治療のイギリス市場規模推移 ・レビー小体型認知症治療のロシア市場規模推移 ・レビー小体型認知症治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・レビー小体型認知症治療の日本市場規模推移 ・レビー小体型認知症治療の中国市場規模推移 ・レビー小体型認知症治療の韓国市場規模推移 ・レビー小体型認知症治療のインド市場規模推移 ・レビー小体型認知症治療の東南アジア市場規模推移 ・レビー小体型認知症治療の南米市場分析（ブラジル、アルゼンチン等） ・レビー小体型認知症治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・レビー小体型認知症治療の種類別分析/販売量、売上、市場シェア（モダフィニル、ベンゾジアゼピン、抗うつ剤、コリンエステラーゼ阻害剤、抗精神病薬、カルビドパ-レボドパ） ・レビー小体型認知症治療の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局） ・レビー小体型認知症治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・レビー小体型認知症治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Lewy body dementia (LBD, sometimes referred to as Lewy body disorder) is an umbrella term that includes Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB), two dementias characterized by abnormal deposits of the protein alpha-synuclein in the brain.
Scope of the Report:
The global Lewy Body Dementia Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lewy Body Dementia Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Lewy Body Dementia Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Lewy Body Dementia Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Novartis
Pfizer
Bayer
GlaxoSmithKline
Mylan
Sanofi
Johnson & Johnson
Teva Pharmaceuticals
Eli Lilly
Eisai
Takeda Pharmaceutical
Allergan
Bausch Health Companies
BioArctic
Sumitomo Dainippon Pharma
Jazz Pharmaceuticals
Hisamitsu Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Modafinil
Benzodiazepine
Antidepressants
Cholinesterase Inhibitors
Antipsychotic Drugs
Carbidopa-Levodopa
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Table of Contents
1 Lewy Body Dementia Treatment Market Overview
1.1 Product Overview and Scope of Lewy Body Dementia Treatment
1.2 Classification of Lewy Body Dementia Treatment by Types
1.2.1 Global Lewy Body Dementia Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Lewy Body Dementia Treatment Revenue Market Share by Types in 2018
1.2.3 Modafinil
1.2.4 Benzodiazepine
1.2.5 Antidepressants
1.2.6 Cholinesterase Inhibitors
1.2.7 Antipsychotic Drugs
1.2.8 Carbidopa-Levodopa
1.3 Global Lewy Body Dementia Treatment Market by Application
1.3.1 Global Lewy Body Dementia Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Lewy Body Dementia Treatment Market by Regions
1.4.1 Global Lewy Body Dementia Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Lewy Body Dementia Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Lewy Body Dementia Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lewy Body Dementia Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Lewy Body Dementia Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lewy Body Dementia Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Lewy Body Dementia Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Lewy Body Dementia Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Lewy Body Dementia Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Lewy Body Dementia Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.2 Lewy Body Dementia Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GlaxoSmithKline Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Mylan
2.5.1 Business Overview
2.5.2 Lewy Body Dementia Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Mylan Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sanofi
2.6.1 Business Overview
2.6.2 Lewy Body Dementia Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Johnson & Johnson
2.7.1 Business Overview
2.7.2 Lewy Body Dementia Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson & Johnson Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Teva Pharmaceuticals
2.8.1 Business Overview
2.8.2 Lewy Body Dementia Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Pharmaceuticals Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Eli Lilly
2.9.1 Business Overview
2.9.2 Lewy Body Dementia Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Eli Lilly Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Eisai
2.10.1 Business Overview
2.10.2 Lewy Body Dementia Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Eisai Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.11 Takeda Pharmaceutical
2.11.1 Business Overview
2.11.2 Lewy Body Dementia Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Takeda Pharmaceutical Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.12 Allergan
2.12.1 Business Overview
2.12.2 Lewy Body Dementia Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Allergan Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.13 Bausch Health Companies
2.13.1 Business Overview
2.13.2 Lewy Body Dementia Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Bausch Health Companies Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.14 BioArctic
2.14.1 Business Overview
2.14.2 Lewy Body Dementia Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 BioArctic Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.15 Sumitomo Dainippon Pharma
2.15.1 Business Overview
2.15.2 Lewy Body Dementia Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Sumitomo Dainippon Pharma Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.16 Jazz Pharmaceuticals
2.16.1 Business Overview
2.16.2 Lewy Body Dementia Treatment Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Jazz Pharmaceuticals Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.17 Hisamitsu Pharmaceutical
2.17.1 Business Overview
2.17.2 Lewy Body Dementia Treatment Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Hisamitsu Pharmaceutical Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Lewy Body Dementia Treatment Market Competition, by Players
3.1 Global Lewy Body Dementia Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Lewy Body Dementia Treatment Players Market Share
3.2.2 Top 10 Lewy Body Dementia Treatment Players Market Share
3.3 Market Competition Trend
4 Global Lewy Body Dementia Treatment Market Size by Regions
4.1 Global Lewy Body Dementia Treatment Revenue and Market Share by Regions
4.2 North America Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
5 North America Lewy Body Dementia Treatment Revenue by Countries
5.1 North America Lewy Body Dementia Treatment Revenue by Countries (2014-2019)
5.2 USA Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
6 Europe Lewy Body Dementia Treatment Revenue by Countries
6.1 Europe Lewy Body Dementia Treatment Revenue by Countries (2014-2019)
6.2 Germany Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
6.4 France Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Lewy Body Dementia Treatment Revenue by Countries
7.1 Asia-Pacific Lewy Body Dementia Treatment Revenue by Countries (2014-2019)
7.2 China Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
7.5 India Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
8 South America Lewy Body Dementia Treatment Revenue by Countries
8.1 South America Lewy Body Dementia Treatment Revenue by Countries (2014-2019)
8.2 Brazil Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Lewy Body Dementia Treatment by Countries
9.1 Middle East and Africa Lewy Body Dementia Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
10 Global Lewy Body Dementia Treatment Market Segment by Type
10.1 Global Lewy Body Dementia Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Lewy Body Dementia Treatment Market Forecast by Type (2019-2024)
10.3 Modafinil Revenue Growth Rate (2014-2024)
10.4 Benzodiazepine Revenue Growth Rate (2014-2024)
10.5 Antidepressants Revenue Growth Rate (2014-2024)
10.6 Cholinesterase Inhibitors Revenue Growth Rate (2014-2024)
10.7 Antipsychotic Drugs Revenue Growth Rate (2014-2024)
10.8 Carbidopa-Levodopa Revenue Growth Rate (2014-2024)
11 Global Lewy Body Dementia Treatment Market Segment by Application
11.1 Global Lewy Body Dementia Treatment Revenue Market Share by Application (2014-2019)
11.2 Lewy Body Dementia Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2014-2019)
11.4 Retail Pharmacies Revenue Growth (2014-2019)
11.5 Online Pharmacies Revenue Growth (2014-2019)
12 Global Lewy Body Dementia Treatment Market Size Forecast (2019-2024)
12.1 Global Lewy Body Dementia Treatment Market Size Forecast (2019-2024)
12.2 Global Lewy Body Dementia Treatment Market Forecast by Regions (2019-2024)
12.3 North America Lewy Body Dementia Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Lewy Body Dementia Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Lewy Body Dementia Treatment Revenue Market Forecast (2019-2024)
12.6 South America Lewy Body Dementia Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Lewy Body Dementia Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Lewy Body Dementia Treatment Picture
Table Product Specifications of Lewy Body Dementia Treatment
Table Global Lewy Body Dementia Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Lewy Body Dementia Treatment Revenue Market Share by Types in 2018
Figure Modafinil Picture
Figure Benzodiazepine Picture
Figure Antidepressants Picture
Figure Cholinesterase Inhibitors Picture
Figure Antipsychotic Drugs Picture
Figure Carbidopa-Levodopa Picture
Table Global Lewy Body Dementia Treatment Revenue (Million USD) by Application (2014-2024)
Figure Lewy Body Dementia Treatment Revenue Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Lewy Body Dementia Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Lewy Body Dementia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Lewy Body Dementia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Lewy Body Dementia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Lewy Body Dementia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Lewy Body Dementia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Lewy Body Dementia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Lewy Body Dementia Treatment Type and Applications
Table Novartis Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Lewy Body Dementia Treatment Type and Applications
Table Pfizer Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Lewy Body Dementia Treatment Type and Applications
Table Bayer Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Lewy Body Dementia Treatment Type and Applications
Table GlaxoSmithKline Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Lewy Body Dementia Treatment Type and Applications
Table Mylan Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Lewy Body Dementia Treatment Type and Applications
Table Sanofi Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Lewy Body Dementia Treatment Type and Applications
Table Johnson & Johnson Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceuticals Lewy Body Dementia Treatment Type and Applications
Table Teva Pharmaceuticals Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Lewy Body Dementia Treatment Type and Applications
Table Eli Lilly Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Lewy Body Dementia Treatment Type and Applications
Table Eisai Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Lewy Body Dementia Treatment Type and Applications
Table Takeda Pharmaceutical Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Lewy Body Dementia Treatment Type and Applications
Table Allergan Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Bausch Health Companies Basic Information, Manufacturing Base and Competitors
Table Bausch Health Companies Lewy Body Dementia Treatment Type and Applications
Table Bausch Health Companies Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table BioArctic Basic Information, Manufacturing Base and Competitors
Table BioArctic Lewy Body Dementia Treatment Type and Applications
Table BioArctic Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sumitomo Dainippon Pharma Basic Information, Manufacturing Base and Competitors
Table Sumitomo Dainippon Pharma Lewy Body Dementia Treatment Type and Applications
Table Sumitomo Dainippon Pharma Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Jazz Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Jazz Pharmaceuticals Lewy Body Dementia Treatment Type and Applications
Table Jazz Pharmaceuticals Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Hisamitsu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Hisamitsu Pharmaceutical Lewy Body Dementia Treatment Type and Applications
Table Hisamitsu Pharmaceutical Lewy Body Dementia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Lewy Body Dementia Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Lewy Body Dementia Treatment Revenue Share by Players (2014-2019)
Figure Global Lewy Body Dementia Treatment Revenue Share by Players in 2017
Figure Global Lewy Body Dementia Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Lewy Body Dementia Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Lewy Body Dementia Treatment Revenue Market Share in 2018
Figure Global Lewy Body Dementia Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Lewy Body Dementia Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Lewy Body Dementia Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Lewy Body Dementia Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Lewy Body Dementia Treatment Revenue Market Share by Regions in 2018
Figure North America Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure South America Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Table North America Lewy Body Dementia Treatment Revenue by Countries (2014-2019)
Table North America Lewy Body Dementia Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Lewy Body Dementia Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Lewy Body Dementia Treatment Revenue Market Share by Countries in 2018
Figure USA Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Table Europe Lewy Body Dementia Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Lewy Body Dementia Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Lewy Body Dementia Treatment Revenue Market Share by Countries in 2018
Figure Germany Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure UK Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure France Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Lewy Body Dementia Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Lewy Body Dementia Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Lewy Body Dementia Treatment Revenue Market Share by Countries in 2018
Figure China Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure India Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Table South America Lewy Body Dementia Treatment Revenue by Countries (2014-2019)
Table South America Lewy Body Dementia Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Lewy Body Dementia Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Lewy Body Dementia Treatment Revenue Market Share by Countries in 2018
Figure Brazil Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Lewy Body Dementia Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Lewy Body Dementia Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Lewy Body Dementia Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Lewy Body Dementia Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Lewy Body Dementia Treatment Revenue and Growth Rate (2014-2019)
Table Global Lewy Body Dementia Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Lewy Body Dementia Treatment Revenue Share by Type (2014-2019)
Figure Global Lewy Body Dementia Treatment Revenue Share by Type (2014-2019)
Figure Global Lewy Body Dementia Treatment Revenue Share by Type in 2019
Table Global Lewy Body Dementia Treatment Revenue Forecast by Type (2019-2024)
Figure Global Lewy Body Dementia Treatment Market Share Forecast by Type (2019-2024)
Figure Global Modafinil Revenue Growth Rate (2014-2019)
Figure Global Benzodiazepine Revenue Growth Rate (2014-2019)
Figure Global Antidepressants Revenue Growth Rate (2014-2019)
Figure Global Cholinesterase Inhibitors Revenue Growth Rate (2014-2019)
Figure Global Antipsychotic Drugs Revenue Growth Rate (2014-2019)
Figure Global Carbidopa-Levodopa Revenue Growth Rate (2014-2019)
Table Global Lewy Body Dementia Treatment Revenue by Application (2014-2019)
Table Global Lewy Body Dementia Treatment Revenue Share by Application (2014-2019)
Figure Global Lewy Body Dementia Treatment Revenue Share by Application (2014-2019)
Figure Global Lewy Body Dementia Treatment Revenue Share by Application in 2019
Table Global Lewy Body Dementia Treatment Revenue Forecast by Application (2019-2024)
Figure Global Lewy Body Dementia Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Lewy Body Dementia Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Lewy Body Dementia Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Lewy Body Dementia Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Lewy Body Dementia Treatment Revenue Market Forecast (2019-2024)
Figure Europe Lewy Body Dementia Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Lewy Body Dementia Treatment Revenue Market Forecast (2019-2024)
Figure South America Lewy Body Dementia Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Lewy Body Dementia Treatment Revenue Market Forecast (2019-2024)
世界のレビー小体型認知症薬市場予測（～2024年） Lewy body dementia (LBD, sometimes referred to as Lewy body disorder) is an umbrella term that includes Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB), two dementias characterized by abnormal deposits of the protein alpha-synuclein in the brain. Scope of the Report: The globa…- 世界の全身イメージング市場予測（～2024年） Whole body imaging refers to the internal display of the entire body in a single procedure. In medical imaging, it may also refer to full-body CT scan or magnetic resonance imaging. Scope of the Report: The global Whole-Body Imaging market is valued at xx million USD in 2018 and is expected to reach…
- 世界のボディコントアリングインプラント市場予測（～2024年） The body contouring implant range includes silicone gel implants for the calves, glutes and the male chest. Scope of the Report: The global Body Contouring Implants market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between…
- 世界の患者用体温モニタリング市場予測（～2024年） Body temperature is a vital sign and it is important to measure it accurately. Scope of the Report: The global Patient Body Temperature Monitoring market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. Th…
- 世界の炎症性皮膚疾患治療市場予測（～2024年） Scope of the Report: The global Inflammatory Skin Diseases Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especiall…